Search results

Order by most recent / most popular / relevance

Results: 1-7 of 7

Patent term extensions and regulatory exclusivities for pharmaceuticals in Asia and South America

Morrison & Foerster LLP
-
Argentina, Brazil, Chile, China, Hong Kong, Japan, Malaysia, Mexico, Philippines, South Korea, Thailand, USA, Vietnam
-
June 27 2012

Patent protection for pharmaceutical products has an impact on the pharmaceutical market and innovation

IBM pays $10 million to settle long-running corruption probe

Morrison & Foerster LLP
-
China, South Korea, USA
-
March 25 2011

After a seven-year investigation, IBM settled SEC charges that IBM had violated internal controls and books and records provisions of the Foreign Corrupt Practices Act

Implications of the Leahy-Smith America Invents Act for Chinese life science companies

Morrison & Foerster LLP
-
China, USA
-
December 15 2011

The Leahy-Smith America Invents Act (AIA) was signed into law by President Barack Obama on September 16, 2011

Frequent issues arising in acquisitions of China life sciences targets

Morrison & Foerster LLP
-
China, USA
-
December 15 2011

China is the world’s third-largest pharmaceuticals market in terms of revenue

Key regulatory development

Morrison & Foerster LLP
-
China, USA
-
December 15 2011

On November 30, the United States Patent and Trademark Office (USPTO) announced a Paris Route and PCT Patent Prosecution Highway (PPH) pilot program with China’s State Intellectual Property Office (SIPO) that became effective on December 1, 2011

FCPA anti-corruption developments: 2012 end of summer round-up

Morrison & Foerster LLP
-
China, France, Global, Haiti, India, Mexico, United Kingdom, USA
-
October 10 2012

While the temperatures rose this summer, the number of Foreign Corrupt Practices Act enforcement actions seems to have cooled off for the first time in the last five years

More good news for Chinese patent defendants seeking to transfer their cases out of the Eastern District of Texas

Morrison & Foerster LLP
-
China, USA
-
April 30 2010

In our Fall 2009 Newsletter, we reported on some recent legal decisions regarding transferring patent cases out of the Eastern District of Texas to a more convenient and favorable court

Search results

Patent term extensions and regulatory exclusivities for pharmaceuticals in Asia and South America

IBM pays $10 million to settle long-running corruption probe

Implications of the Leahy-Smith America Invents Act for Chinese life science companies

Frequent issues arising in acquisitions of China life sciences targets

Key regulatory development

FCPA anti-corruption developments: 2012 end of summer round-up

More good news for Chinese patent defendants seeking to transfer their cases out of the Eastern District of Texas

Current Search

Suggested Facets

Author

Jurisdiction

Workarea